Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
S

SOPH

Nasdaq

SOPHiA GENETICS SA

Latest disclosureOctober 7, 2026
Insider score Why 7?
7/ 100
Qualifying buys · 30d
$0

1 purchases · 139 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 200

Limited filing history
All200Buying1Selling139Other60
Filters

Last 30 daysNo qualifying insider buying. Sales: $912.77K by 10 insiders.

60 of 200 trades · March 31, 2026 – October 5, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 60 trades on this page.

Exercise or conversion

Manuela Valente

Chief People Officer

Ordinary Shares

Value context
$32K
Reported price
$3.20 / share
Traded August 19, 2026Filed August 21, 2026SEC filing
Exercise or conversion

Manuela Valente

Chief People Officer

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.20 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 19, 2026Filed August 21, 2026SEC filing
Exercise or conversion

Zhenyu Xu

Chief Scientific Officer

Ordinary Shares

Value context
$9.84K
Reported price
$3.28 / share
Traded August 5, 2026Filed August 7, 2026SEC filing
Exercise or conversion

Zhenyu Xu

Chief Scientific Officer

Ordinary Shares

Value context
$22.96K
Reported price
$3.28 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Exercise or conversion

Zhenyu Xu

Chief Scientific Officer

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.28 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 5, 2026Filed August 7, 2026SEC filing
Exercise or conversion

Zhenyu Xu

Chief Scientific Officer

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.28 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 7, 2026Filed August 7, 2026SEC filing
Exercise or conversion

Jurgi Camblong

Executive Chairman

Ordinary Shares

Value context
$14.48K
Reported price
$3.16 / share
Traded July 20, 2026Filed July 22, 2026SEC filing
Exercise or conversion

Jurgi Camblong

Executive Chairman

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 20, 2026Filed July 22, 2026SEC filing
Exercise or conversion

Jurgi Camblong

Executive Chairman

Ordinary Shares

Value context
$57.07K
Reported price
$3.16 / share
Traded June 29, 2026Filed July 1, 2026SEC filing
Exercise or conversion

Jurgi Camblong

Executive Chairman

Ordinary Shares

Value context
$143.52K
Reported price
$3.16 / share
Traded June 30, 2026Filed July 1, 2026SEC filing
Exercise or conversion

Jurgi Camblong

Executive Chairman

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 29, 2026Filed July 1, 2026SEC filing
Exercise or conversion

Jurgi Camblong

Executive Chairman

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 30, 2026Filed July 1, 2026SEC filing
Exercise or conversion

Jurgi Camblong

Chief Executive Officer

Ordinary Shares

Value context
$100.93K
Reported price
$3.16 / share
Traded June 26, 2026Filed June 29, 2026SEC filing
Exercise or conversion

Jurgi Camblong

Chief Executive Officer

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 26, 2026Filed June 29, 2026SEC filing
Award disclosed

Troy Cox

Director

Ordinary Shares

Value context
$107.69K
Reported price
$5.46 / share
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Troy Cox

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
$157.35K
Reported price
$5.46 / derivative unit
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Kathy L. Hibbs

Director

Ordinary Shares

Value context
$107.69K
Reported price
$5.46 / share
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Kathy L. Hibbs

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
$157.35K
Reported price
$5.46 / derivative unit
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Vincent Ossipow

Director

Ordinary Shares

Value context
$107.69K
Reported price
$5.46 / share
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Vincent Ossipow

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
$157.35K
Reported price
$5.46 / derivative unit
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Jean-Michel Cossery

Director

Ordinary Shares

Value context
$107.69K
Reported price
$5.46 / share
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Jean-Michel Cossery

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
$157.35K
Reported price
$5.46 / derivative unit
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Didier Hirsch

Director

Ordinary Shares

Value context
$107.69K
Reported price
$5.46 / share
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosed

Didier Hirsch

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
$157.35K
Reported price
$5.46 / derivative unit
Traded June 18, 2026Filed June 22, 2026SEC filing
Award disclosedAmended filing

Well Daan Van

Chief Legal Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Well Daan Van

Chief Legal Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Ross Muken

President

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Ross Muken

President

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

George Cardoza

Chief Financial Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

George Cardoza

Chief Financial Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Jurgi Camblong

Chief Executive Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Jurgi Camblong

Chief Executive Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Philippe Menu

Chief Medical Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Philippe Menu

Chief Medical Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Kevin Puylaert

Chief Sales Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Kevin Puylaert

Chief Sales Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Manuela Valente

Chief People Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Manuela Valente

Chief People Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Zhenyu Xu

Chief Scientific Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Zhenyu Xu

Chief Scientific Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Abhimanyu Verma

Chief Technology Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosedAmended filing

Abhimanyu Verma

Chief Technology Officer

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 8, 2026SEC filing
Award disclosed

Abhimanyu Verma

Chief Technology Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Abhimanyu Verma

Chief Technology Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Ross Muken

President

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Ross Muken

President

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Philippe Menu

Chief Medical Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Philippe Menu

Chief Medical Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Zhenyu Xu

Chief Scientific Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Zhenyu Xu

Chief Scientific Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Jurgi Camblong

Chief Executive Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Jurgi Camblong

Chief Executive Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Kevin Puylaert

Chief Sales Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Kevin Puylaert

Chief Sales Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

George Cardoza

Chief Financial Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

George Cardoza

Chief Financial Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Manuela Valente

Chief People Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Manuela Valente

Chief People Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Well Daan Van

Chief Legal Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Award disclosed

Well Daan Van

Chief Legal Officer

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 2, 2026Filed April 3, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief People OfficerOrdinary SharesOption exercise or conversion10b5-110,000$3.20 / share$32KAug 19Filed Aug 21 · 2d laterSEC filing
Chief People OfficerShare Option (Right to Buy)Option exercise or conversion10b5-1Derivative units10,000$3.20 exercise / conversion priceNot a separate purchaseAug 19Filed Aug 21 · 2d laterSEC filing
Chief Scientific OfficerOrdinary SharesOption exercise or conversion10b5-13,000$3.28 / share$9.84KAug 5Filed Aug 7 · 2d laterSEC filing
Chief Scientific OfficerOrdinary SharesOption exercise or conversion10b5-17,000$3.28 / share$22.96KAug 7Filed Aug 7 · 0d laterSEC filing
Chief Scientific OfficerShare Option (Right to Buy)Option exercise or conversion10b5-1Derivative units3,000$3.28 exercise / conversion priceNot a separate purchaseAug 5Filed Aug 7 · 2d laterSEC filing
Chief Scientific OfficerShare Option (Right to Buy)Option exercise or conversion10b5-1Derivative units7,000$3.28 exercise / conversion priceNot a separate purchaseAug 7Filed Aug 7 · 0d laterSEC filing
Executive ChairmanOrdinary SharesOption exercise or conversion10b5-14,581$3.16 / share$14.48KJul 20Filed Jul 22 · 2d laterSEC filing
Executive ChairmanShare Option (Right to Buy)Option exercise or conversion10b5-1Derivative units4,581$3.16 exercise / conversion priceNot a separate purchaseJul 20Filed Jul 22 · 2d laterSEC filing
Executive ChairmanOrdinary SharesOption exercise or conversion10b5-118,060$3.16 / share$57.07KJun 29Filed Jul 1 · 2d laterSEC filing
Executive ChairmanOrdinary SharesOption exercise or conversion10b5-145,419$3.16 / share$143.52KJun 30Filed Jul 1 · 1d laterSEC filing
Executive ChairmanShare Option (Right to Buy)Option exercise or conversion10b5-1Derivative units18,060$3.16 exercise / conversion priceNot a separate purchaseJun 29Filed Jul 1 · 2d laterSEC filing
Executive ChairmanShare Option (Right to Buy)Option exercise or conversion10b5-1Derivative units45,419$3.16 exercise / conversion priceNot a separate purchaseJun 30Filed Jul 1 · 1d laterSEC filing
Chief Executive OfficerOrdinary SharesOption exercise or conversion10b5-131,940$3.16 / share$100.93KJun 26Filed Jun 29 · 3d laterSEC filing
Chief Executive OfficerShare Option (Right to Buy)Option exercise or conversion10b5-1Derivative units31,940$3.16 exercise / conversion priceNot a separate purchaseJun 26Filed Jun 29 · 3d laterSEC filing
DirectorOrdinary SharesGrant or award19,724$5.46 / share$107.69KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units28,818$5.46 / derivative unit$157.35KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorOrdinary SharesGrant or award19,724$5.46 / share$107.69KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units28,818$5.46 / derivative unit$157.35KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorOrdinary SharesGrant or award19,724$5.46 / share$107.69KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units28,818$5.46 / derivative unit$157.35KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorOrdinary SharesGrant or award19,724$5.46 / share$107.69KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units28,818$5.46 / derivative unit$157.35KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorOrdinary SharesGrant or award19,724$5.46 / share$107.69KJun 18Filed Jun 22 · 4d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units28,818$5.46 / derivative unit$157.35KJun 18Filed Jun 22 · 4d laterSEC filing
Chief Legal Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award97,536Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Legal Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units142,216Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
President
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award431,211Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
President
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units628,743Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Financial Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award112,936Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Financial Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units164,671Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Executive Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award431,211Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Executive Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units628,743Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Medical Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award112,936Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Medical Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units164,671Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Sales Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award56,468Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Sales Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units82,335Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief People Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award71,869Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief People Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units104,790Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Scientific Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award112,936Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Scientific Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units164,671Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Technology Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Ordinary SharesGrant or award82,136Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Technology Officer
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Share Option (Right to Buy)Grant or awardDerivative units119,760Award · no purchase priceNon-cash awardApr 2Filed Apr 8 · 6d laterSEC filing
Chief Technology Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award82,136Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Technology Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units119,760Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
President
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award431,211Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
President
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units628,743Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Medical Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award112,936Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Medical Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units164,671Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Scientific Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award112,936Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Scientific Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units164,671Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Executive Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award431,211Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Executive Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units628,743Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Sales Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award56,468Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Sales Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units82,335Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Financial Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award112,936Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Financial Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units164,671Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief People Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award71,869Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief People Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units104,790Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Legal Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Ordinary SharesGrant or award97,536Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing
Chief Legal Officer
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Share Option (Right to Buy)Grant or awardDerivative units142,216Award · no purchase priceNon-cash awardApr 2Filed Apr 3 · 1d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for SOPH in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$24,750 of common-equity purchase value after transaction-age decay across 180 days.

+2 pts

Distinct buying groups

1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+2 pts

CFO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+3 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001840706
Latest public acceptance
Oct 7, 2026, 08:04 PM UTC
Score calculated
Oct 8, 2026, 12:10 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.